Literature DB >> 1314026

Immunocytochemical characteristics of small cell lung carcinoma associated with the Lambert-Eaton myasthenic syndrome.

C S Morris1, M M Esiri, A Marx, J Newsom-Davis.   

Abstract

The Lambert-Eaton myasthenic syndrome (LEMS) is characterized by the presence of IgG antibodies to motor nerve terminals, and associates with small cell lung carcinoma in more than 60% of cases. We have carried out a comparative immunocytochemical study on small cell lung carcinoma (SCLC) in five LEMS cases and six non-LEMS cases, using antibodies to tumor markers, MHC Class I and II, macrophages and lymphocytes. The authors found a reduced expression of the 200Kd neurofilament antigen and of MHC Class I antigens in the LEMS cases as well as a greater infiltration of activated macrophages. It is suggested that these findings are consistent with the view that SCLC antigenic determinants trigger the autoantibody response in SCLC-LEMS.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1314026      PMCID: PMC1886379     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  27 in total

1.  Immunohistochemical analysis of the immune reaction in the nervous system in paraneoplastic encephalomyelitis.

Authors:  F Graus; T Ribalta; E Campo; R Monforte; A Urbano; C Rozman
Journal:  Neurology       Date:  1990-02       Impact factor: 9.910

2.  Specificity of calcium channel autoantibodies in Lambert-Eaton myasthenic syndrome.

Authors:  E Sher; C Gotti; N Canal; C Scoppetta; G Piccolo; A Evoli; F Clementi
Journal:  Lancet       Date:  1989-09-16       Impact factor: 79.321

3.  A clinical triad to diagnose paraneoplastic retinopathy.

Authors:  D M Jacobson; C E Thirkill; S J Tipping
Journal:  Ann Neurol       Date:  1990-08       Impact factor: 10.422

4.  Lambert-Eaton myasthenic syndrome: immunoglobulin G inhibition of Ca2+ flux in tumor cells correlates with disease severity.

Authors:  B Lang; A Vincent; N M Murray; J Newsom-Davis
Journal:  Ann Neurol       Date:  1989-03       Impact factor: 10.422

5.  Antibodies to motor nerve terminals: an electrophysiological study of a human myasthenic syndrome transferred to mouse.

Authors:  B Lang; J Newsom-Davis; C Prior; D Wray
Journal:  J Physiol       Date:  1983-11       Impact factor: 5.182

6.  Linkage of faulty major histocompatibility complex class I to autoimmune diabetes.

Authors:  D Faustman; X P Li; H Y Lin; Y E Fu; G Eisenbarth; J Avruch; J Guo
Journal:  Science       Date:  1991-12-20       Impact factor: 47.728

7.  Sensory neuronopathy and small cell lung cancer. Antineuronal antibody that also reacts with the tumor.

Authors:  F Graus; K B Elkon; C Cordon-Cardo; J B Posner
Journal:  Am J Med       Date:  1986-01       Impact factor: 4.965

8.  Autoimmune basis for visual paraneoplastic syndrome in patients with small-cell lung carcinoma.

Authors:  G B Grunwald; R Klein; M A Simmonds; S E Kornguth
Journal:  Lancet       Date:  1985-03-23       Impact factor: 79.321

9.  The Lambert-Eaton myasthenic syndrome. A review of 50 cases.

Authors:  J H O'Neill; N M Murray; J Newsom-Davis
Journal:  Brain       Date:  1988-06       Impact factor: 13.501

Review 10.  Autoimmunity to the voltage-gated calcium channel underlies the Lambert-Eaton myasthenic syndrome, a paraneoplastic disorder.

Authors:  A Vincent; B Lang; J Newsom-Davis
Journal:  Trends Neurosci       Date:  1989-12       Impact factor: 13.837

View more
  3 in total

Review 1.  Immunopathology of the Lambert-Eaton myasthenic syndrome.

Authors:  B Lang; J Newsom-Davis
Journal:  Springer Semin Immunopathol       Date:  1995

2.  Lambert-eaton myasthenic syndrome; pathogenesis, diagnosis, and therapy.

Authors:  Nils Erik Gilhus
Journal:  Autoimmune Dis       Date:  2011-09-29

Review 3.  [Immune Characteristics of Small Cell Lung Cancer].

Authors:  Yan Zhu; Shikai Wu
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2020-10-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.